Screener
Xeris Biopharma Holdings, Inc. XERS Other product revenue — Product revenue, net
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Xeris Biopharma Holdings, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001867096-26-000065
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Product revenue: | ||||
| Recorlev | $56,780 | $31,444 | $106,548 | $56,974 |
| Gvoke | 22,549 | 23,467 | 43,349 | 44,312 |
| Keveyis | 11,675 | 11,485 | 23,561 | 22,912 |
| Other product revenue | — | 1,312 | — | 1,312 |
| Product revenue, net | 91,004 | 67,708 | 173,458 | 125,510 |
| Royalty, contract and other revenue | 1,096 | 3,831 | 1,769 | 6,148 |
| Total revenue | $92,100 | $71,539 | $175,227 | $131,658 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Xeris Biopharma Holdings, Inc.'s other product revenue — product revenue, net?
- Xeris Biopharma Holdings, Inc. (XERS) reported other product revenue — product revenue, net of $0 in Q2 2026.
- How has Xeris Biopharma Holdings, Inc.'s other product revenue — product revenue, net changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s other product revenue — product revenue, net decreased by 100.0% year-over-year, from $1.31M to $0.
- What does other product revenue — product revenue, net mean?
- This metric represents the net revenue generated from secondary or emerging product lines that fall outside the company's primary therapeutic franchises. It tracks the commercial performance and market adoption of niche or newly launched assets within the biopharmaceutical portfolio. Monitoring this revenue stream provides insight into the company's ability to diversify its income base beyond core flagship therapies.
Ask your AI about Xeris Biopharma Holdings, Inc.'s other product revenue — product revenue, net.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude